Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Structural and functional studies of rhomboid protease PARL (Presenillin-Associated Rhomboid-Like) in Parkinson's disease

FY 2014-15

Summary
Cell viability relies on a careful balance of fission and fusion of the mitochondria, the energy producing organelle. Disruption of this balance leads to cell death, as observed in the dopaminergic neurons in Parkinson’s Disease (PD). Mitochondrial fusion requires proper function of the intramembrane rhomboid protease PARL (Presenillin-Associated Rhomboid-Like). PARL cleaves transmembrane substrates, including PINK1 (Phosphatase-Tensin homologue (PTEN)-Induced protein Kinase). Uncleaved PINK1 recruits Parkin to the mitochondria, resulting in mitophagy, the process of mitochondrial degradation. Some inherited mutations of PINK1 are linked to PD. It is not yet known how these mutations to PINK1 influence cleavage by PARL. We hypothesise that PINK1 mutations decrease the cleavage rate by PARL, thus increasing mitophagy and leading to PD. Our lab has already successfully expressed and purified PARL in Pichia pastoris. We have also expressed full-length PINK1 in mouse embryonic stem cells, and the transmembrane domain in Escherichia coli. I will now elucidate the mechanism of PINK1 cleavage by PARL using a steady-state kinetics assay developed by our lab. With this assay, I will determine if the mutations in PINK1 linked to PD will reduce its cleavage rate by PARL. I will also determine the structure of PARL using crystallography. This high-resolution structure will provide insight into the mechanism by which PARL cleaves PINK1 and other transmembrane proteins; it would also be the first structure of a rhomboid protease with a 6+1 transmembrane helix architecture. From these experiments, I will determine the mechanism of cleavage of PINK1 by PARL, facilitating the development of novel therapeutics against PINK1 associated PD.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331238
Name
Smithers Cameron C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Structural and functional studies of rhomboid protease PARL (Presenillin-Associated Rhomboid-Like) in Parkinson's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Enzymatic Assay; Intramembrane Proteolysis; Membrane Protein; Mitochondria; Mitophagy; Parkinson'S Disease; Parl; Pink1; Rhomboid Protease; Signalling
Abstract
Cell viability relies on a careful balance of fission and fusion of the mitochondria, the energy producing organelle. Disruption of this balance leads to cell death, as observed in the dopaminergic neurons in Parkinson’s Disease (PD). Mitochondrial fusion requires proper function of the intramembrane rhomboid protease PARL (Presenillin-Associated Rhomboid-Like). PARL cleaves transmembrane substrates, including PINK1 (Phosphatase-Tensin homologue (PTEN)-Induced protein Kinase). Uncleaved PINK1 recruits Parkin to the mitochondria, resulting in mitophagy, the process of mitochondrial degradation. Some inherited mutations of PINK1 are linked to PD. It is not yet known how these mutations to PINK1 influence cleavage by PARL. We hypothesise that PINK1 mutations decrease the cleavage rate by PARL, thus increasing mitophagy and leading to PD. Our lab has already successfully expressed and purified PARL in Pichia pastoris. We have also expressed full-length PINK1 in mouse embryonic stem cells, and the transmembrane domain in Escherichia coli. I will now elucidate the mechanism of PINK1 cleavage by PARL using a steady-state kinetics assay developed by our lab. With this assay, I will determine if the mutations in PINK1 linked to PD will reduce its cleavage rate by PARL. I will also determine the structure of PARL using crystallography. This high-resolution structure will provide insight into the mechanism by which PARL cleaves PINK1 and other transmembrane proteins; it would also be the first structure of a rhomboid protease with a 6+1 transmembrane helix architecture. From these experiments, I will determine the mechanism of cleavage of PINK1 by PARL, facilitating the development of novel therapeutics against PINK1 associated PD.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smithers, Cameron C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~